Results 241 to 250 of about 1,953,986 (355)

Introducing AI & Innovation

open access: yes
AI &Innovation, EarlyView.
Mirko Farina   +7 more
wiley   +1 more source

Sitting in Many Camps—Innovative Approaches and Methods for First Nations‐Led Research Into Indigenous Peacebuilding

open access: yesAustralian Journal of Social Issues, EarlyView.
ABSTRACT In 2021, a desktop review was conducted of published references to First Nations peoples' approaches to conflict and its management in Australia (Project Stage One), culminating in a report published in 2024. This article focuses on Project Stage Two, a complex, innovative research undertaking building on the findings of Stage One, and being ...
Helen Bishop   +3 more
wiley   +1 more source

Inverting the Circularly Polarized Luminescence Handedness of Chiral Supramolecular Polymers Using Temperature

open access: yesAngewandte Chemie, EarlyView.
The supramolecular polymerization of enantiopure triarylamine trisamide monomers bearing aggregation‐induced emissive tetraphenylethene units, gave rise to a strong circularly polarized luminescence (with glum values as high as |1.8·10−2|). Strikingly, upon fast versus slow cooling rates, these monomers formed distinct hierarchical self‐assemblies (i.e.
Teodor‐Aurelian Cucuiet   +7 more
wiley   +2 more sources

AI in Neurology: Everything, Everywhere, All at Once Part 3: Surveillance, Synthesis, Simulation, and Systems

open access: yesAnnals of Neurology, EarlyView.
This final part 3 review builds on the practical applications discussed in part 2 and explores how artificial intelligence (AI) is transforming data management, neurological education, and neurological care across large healthcare networks and datasets. The review also highlights AI's role in real‐world and synthetic data, digital twins, and innovative
Matthew Rizzo
wiley   +1 more source

Back Again to the Future: A New Era for Cerebroprotection

open access: yesAnnals of Neurology, EarlyView.
Cerebroprotection is a fresh framework for designing neurological therapy that targets glia and vascular cells, in addition to neurons. In the future, successful cerebroprotection will involve targeting all elements of the neurovascular unit. Preclinical trials must include functional outcomes, as well as lesion morphometry.
Patrick Lyden
wiley   +1 more source

Home - About - Disclaimer - Privacy